| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Sandra I. Coufal | Director, 10%+ Owner | Jun 15, 2022 | |||
| Orbimed Advisors Llc | Director, 10%+ Owner | Nov 22, 2022 | |||
| Kathryn E. Falberg | Director | Jun 15, 2022 | |||
| Venrock Healthcare Capital Partners II, L.P. | 10%+ Owner | Oct 24, 2022 | |||
| Robert J. Alpern | Director | Nov 23, 2022 | |||
| Robert McKague | EVP, General Counsel | Feb 28, 2022 | |||
| Gerrit Klaerner | President and CEO, Director | Feb 28, 2022 | |||
| David Hirsch | Director | Jun 15, 2022 | |||
| Wilhelm Stahl | EVP, Chief Tech Officer | Dec 31, 2021 | |||
| Klaus R. Dr Veitinger | Director | Jun 15, 2022 | |||
| Geoffrey Parker | COO, CFO and EVP | Feb 28, 2022 | |||
| David P. Bonita | Director, 10%+ Owner | Nov 22, 2022 | |||
| Brian M. Isern | *possible member of 10% group, 10%+ Owner | Oct 11, 2022 | |||
| Dawn Parsell Otto | EVP, Clinical Development | Feb 28, 2022 | |||
| Annie Yoshiyama | Senior VP, Finance and CAO | Aug 5, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|